U.S. Nanocapsules Market was valued at USD 1.43 billion in 2025 and is expected to reach USD 2.27 billion by 2035 due to growing research and development activities in the U.S.
Austin, March 26, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, the Nanocapsules Market size was valued at USD 3.75 billion in 2025 and is expected to reach USD 5.92 billion by 2035, growing at a CAGR of 4.68% over 2026-2035.
The market for nanocapsules is expanding steadily and rapidly, primarily due to an increasing number of sectors discovering the potential advantages of nanotechnology for product delivery. The growing investments in nanomedicine R&D, the availability of a favorable regulatory environment for nano-enabled drug delivery in the U.S. and European markets.
Nanocapsules Market Size and Forecast:
- Market Size in 2025: USD 3.75 billion
- Market Size by 2035: USD 5.92 billion
- CAGR: 4.68% from 2026 to 2035
- Base Year: 2025
- Forecast Period: 2026–2035
- Historical Data: 2022–2024
Instantly Access the Sample Report of Nanocapsules Market Forecast @ https://www.snsinsider.com/sample-request/6941
The U.S. Nanocapsules Market was valued at USD 1.43 billion in 2025 and is expected to reach USD 2.27 billion by 2035, growing at a CAGR of 4.72% over 2026-2035.
The U.S. market growth is driven by the research & development activities for pharmaceutical products, quality of existing CMO infrastructure for nanoscale formulation work and regulatory framework improving for nanotechnology-enabled drug products by FDA.
Rising Demand for Targeted Drug Delivery in Oncology to Propel Market Expansion Globally
The demand for a more precise and accurate way to distribute cancer medications may be one of the most obvious and real market drivers of a developing nanocapsule market. It has been demonstrated that the existing chemotherapeutic approach is inadequate in several respects. It has been demonstrated to have dose-limiting adverse effects and to be systemically toxic. The chemotherapeutic agent can be encapsulated by the nanocapsule and subsequently delivered to the intended location. The agent is encased in a membrane to do this. The World Health Organization estimates that there will be more than 35 million instances of cancer by 2050, making the necessity to address this emerging field of study more apparent.
Nanocapsules Market Segmentation Analysis:
By Application
The healthcare segment held the largest revenue share of around 52.40% in 2025 due to the high degree of nanocapsule technology incorporation in pharmaceutical drug delivery systems globally. The food and nutraceuticals industry is projected to record the highest CAGR of around 6.12% during the forecast period of 2026-2035 due to an increase in consumer interest in high bioavailability ingredients for supplement formulation globally.
By Therapeutic Area
Therapeutic area share of oncology is also prominent accounting for 44.27% in 2025, supported by broad clinical adoption of nano-formulated cytotoxic agents globally. During the period 2026 to 2035, the highest approximate CAGR of 5.87% is projected for the endocrinology segment, attributed to the increase in demand for nanocapsule-insulin delivery systems and stabilization platform for peptide hormones globally.
Get Expert-Led Insights for Your Business Strategy — Connect with Analysts Now @ https://www.snsinsider.com/request-analyst/6941
Nanocapsules Market Regional Insights:
With a compound annual growth rate (CAGR) of 6.84%, Asia Pacific is the market leader in nanocapsule growth. This is due to the rapidly growing pharmaceutical manufacturing base, the growing government nanotechnology research base, and the vast and growing population base of affluent consumers eager to adopt premium food and healthcare products.
Due to the U.S.’s dominance in pharmaceutical innovation, the presence of the most advanced contract manufacturing infrastructure for nanotechnology, and a readily funded community of investors interested in funding nanomedicine start-up and scale-up platforms, North America contributed a maximum share of 38.42% of market revenue in 2025.
Major Players Analysis Listed in the Nanocapsules Market Report:
- BASF SE
- Evonik Industries AG
- Croda International Plc
- Givaudan SA
- International Flavors & Fragrances Inc. (IFF)
- Lonza Group AG
- Syngenta AG
- Encapsys LLC
- Microtek Laboratories Inc.
- Cabot Corporation
- NanoViricides Inc.
- Nanobiotix SA
- Nanoform Finland Plc
- Lubrizol Corporation (Particle Sciences)
- Roquette Freres SA
- Ashland Inc.
- Adare Pharmaceuticals Inc.
- Solvay SA
- Thermo Fisher Scientific Inc.
- Southwest Research Institute (SwRI)
Nanocapsules Market Recent Developments:
- In February 2025, BASF expanded its pharmaceutical excipients portfolio with the commercial launch of a new grade of Kollicoat polymer specifically optimized for lipid-polymer hybrid nanocapsule formulations, targeting improved drug loading efficiency and gastrointestinal stability for oral oncology and endocrinology drug applications.
- In June 2024, Evonik announced the expansion of its Health Care business unit’s nanotechnology capabilities through the inauguration of a dedicated lipid nanoparticle and nanocapsule process development laboratory in Darmstadt, Germany, designed to accelerate CDMO services for pharmaceutical clients advancing nano-formulated drug candidates through clinical development.
Purchase Single User PDF of Nanocapsules Market Report @ https://www.snsinsider.com/checkout/6941
Exclusive Sections of the Report (The USPs):
- DRUG LOADING & ENCAPSULATION PERFORMANCE METRICS – helps you understand formulation efficiency through encapsulation benchmarks, particle size stability, zeta potential analysis, and comparative drug release kinetics across nanocapsule platforms.
- CONTROLLED RELEASE & BIOAVAILABILITY INSIGHTS – helps you evaluate therapeutic effectiveness through analysis of payload release mechanisms, including stimuli-responsive vs. passive systems, and in vitro–in vivo correlation across therapeutic areas.
- NANOTOXICOLOGY & BIOCOMPATIBILITY ASSESSMENT METRICS – helps you assess safety profiles through cytotoxicity, genotoxicity, immunogenicity, and biodistribution studies, along with regulatory submission trends across major agencies.
- MANUFACTURING SCALE-UP & PROCESS EFFICIENCY METRICS – helps you identify production feasibility through batch reproducibility, GMP yield efficiency, cost-per-gram analysis, and adoption of advanced manufacturing technologies such as microfluidics and PAT systems.
- TECHNOLOGY TRANSFER & COMMERCIALIZATION SUCCESS RATES – helps you evaluate scalability by tracking success rates in transitioning from lab-scale to pilot and commercial manufacturing environments.
- REGULATORY APPROVAL & COMPLIANCE TIMELINE METRICS – helps you understand market entry dynamics through IND-to-NDA timelines, compliance with nanotechnology guidelines, expedited approval pathways, and post-market surveillance trends.
Nanocapsules Market Report Scope:
| Report Attributes | Details |
| Market Size in 2025 | USD 3.58 Billion |
| Market Size by 2035 | USD 5.92 Billion |
| CAGR | CAGR of 4.68% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Application [Healthcare, Food & Nutraceuticals, Cosmetics, Others] • By Therapeutic Area [Oncology, Pain Management, Endocrinology, Others] |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Demand for Industry Analysis: Our Comprehensive Report Nanocapsules Market @ https://www.snsinsider.com/reports/nanocapsules-market-6941
Other Related Report:
Capsule Endoscopy Market
Halal Empty Capsules Market
Empty Capsules Market
Softgel Capsule Market
Nanomedicine Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Data Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.